Method for the Detection of Dysfunctional High Density Lipoprotein (HDL) prior to the administration of HDL raising drugs
The invention describes a new method for the detection of dysfunctional High Density Lipoprotein (HDL) prior to the administration of HDL raising drugs. HDL from patients with mild to severe CKD, is specifically associated with a component of human blood plasma which alters the endothelial effects of HDL. This novel pathomechanism leads to a HDL phenotype promoting hypertension and likely accelerating atherosclerosis even in incipient CKD that may contribute to elevated cardiovascular morbidity and mortality.
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-71302
Contact
Dipl.-Kfm. Axel Koch (MBA), Dr. Conny Clausen, Dr. Nicole Comtesse, Dr. Frank Döbrich
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Sea slugs inspire highly stretchable biomedical sensor
USC Viterbi School of Engineering researcher Hangbo Zhao presents findings on highly stretchable and customizable microneedles for application in fields including neuroscience, tissue engineering, and wearable bioelectronics. The revolution in…
Twisting and binding matter waves with photons in a cavity
Precisely measuring the energy states of individual atoms has been a historical challenge for physicists due to atomic recoil. When an atom interacts with a photon, the atom “recoils” in…
Nanotubes, nanoparticles, and antibodies detect tiny amounts of fentanyl
New sensor is six orders of magnitude more sensitive than the next best thing. A research team at Pitt led by Alexander Star, a chemistry professor in the Kenneth P. Dietrich…
